Taisho Pharmaceutical Holdings Co Ltd (TAIPY)
12.00
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
Taisho Pharmaceutical Holdings Enterprise Value: -1.710B for July 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| July 02, 2024 | -1.710B |
| July 01, 2024 | -1.710B |
| June 28, 2024 | -1.710B |
| June 27, 2024 | -1.710B |
| June 26, 2024 | -1.710B |
| June 25, 2024 | -1.710B |
| June 24, 2024 | -1.710B |
| June 21, 2024 | -1.710B |
| June 20, 2024 | -1.710B |
| June 18, 2024 | -1.710B |
| June 17, 2024 | -1.710B |
| June 14, 2024 | -1.710B |
| June 13, 2024 | -1.710B |
| June 12, 2024 | -1.710B |
| June 11, 2024 | -1.710B |
| June 10, 2024 | -1.710B |
| June 07, 2024 | -1.710B |
| June 06, 2024 | -1.710B |
| June 05, 2024 | -1.710B |
| June 04, 2024 | -1.710B |
| June 03, 2024 | -1.710B |
| May 31, 2024 | -1.710B |
| May 30, 2024 | -1.710B |
| May 29, 2024 | -1.710B |
| May 28, 2024 | -1.710B |
| Date | Value |
|---|---|
| May 24, 2024 | -1.710B |
| May 23, 2024 | -1.710B |
| May 22, 2024 | -1.710B |
| May 21, 2024 | -1.710B |
| May 20, 2024 | -1.710B |
| May 17, 2024 | -1.710B |
| May 16, 2024 | -1.710B |
| May 15, 2024 | -1.710B |
| May 14, 2024 | -1.710B |
| May 13, 2024 | -1.710B |
| May 10, 2024 | -1.710B |
| May 09, 2024 | -1.710B |
| May 08, 2024 | -1.710B |
| May 07, 2024 | -1.710B |
| May 06, 2024 | -1.710B |
| May 03, 2024 | -1.710B |
| May 02, 2024 | -1.710B |
| May 01, 2024 | -1.710B |
| April 30, 2024 | -1.710B |
| April 29, 2024 | -1.710B |
| April 26, 2024 | -1.710B |
| April 25, 2024 | -1.710B |
| April 24, 2024 | -1.710B |
| April 23, 2024 | -1.710B |
| April 22, 2024 | -1.710B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.219B
Minimum
Jul 03 2019
-1.580B
Maximum
Sep 30 2023
-1.951B
Average
-1.910B
Median
Jun 30 2020
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 69.77B |
| Nxera Pharma Co Ltd | 983.06M |
| PeptiDream Inc | 1.815B |
| Healios KK | 83.01M |
| AnGes Inc | 59.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.46M |
| Revenue (Quarterly) | 566.03M |
| Total Expenses (Quarterly) | 548.03M |
| EPS Diluted (Quarterly) | 1.621M |
| Gross Profit Margin (Quarterly) | 55.61% |
| Profit Margin (Quarterly) | 3.44% |
| Earnings Yield | 40.16M% |
| Operating Earnings Yield | 92.89M% |